ICT-AI Platform Initiative
First written in FY2019. 7 of 8 entries say "Advanced", first in FY2020. Latest entry: FY2026.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Company expects to connect up to 5% of its core products to this cloud- and AI-enabled platform by the fiscal year ending March 2028 and increase the proportion to 25% by the fiscal year ending March 2031.」
Regarding OLYSENSE, the Company indicated plans to launch multiple CAD products in parts of the United States and Europe in the fiscal year ending March 2026, and to increase the connection rate for core products to up to 5% by the fiscal year ending March 2028 and 25% by the fiscal year ending March 2031. - FY2025AdvancedAnnual report
「In the fiscal year ending March 2026, the Company plans to launch OLYSENSE, a new sub-brand offering cloud-based integrated endoscopy applications and solutions, and to roll out CADIIE, a CAD/AI product supporting the detection, differentiation and analysis of upper and lower gastrointestinal lesions in Europe and the United States.」
Regarding the ICT-AI Platform Initiative, the Company explicitly announced the launch of OLYSENSE in the fiscal year ending March 2026 and plans to roll out CADIIE in Europe and the United States. - FY2023AdvancedAnnual report
「To address these challenges, the Company is considering providing solutions through intelligent endoscopic care using connectivity, AI and data insights, and will standardize the user experience through workflow management, CAD and real-time procedural support, and AI-generated clinical and operational insights.」
The ICT-AI Platform Initiative was expanded into an endoscopic care ecosystem using connectivity, AI and data insights. - FY2023-Q3AdvancedAnnual report
「On 19 December 2022, the Company acquired all issued shares of Odin Medical Ltd. through its consolidated subsidiary Keymed (Medical & Industrial Equipment) Ltd.」
Regarding the ICT-AI Platform Initiative, the Company acquired all shares of Odin Medical Ltd., which develops cloud-based AI-enabled applications for endoscopy, on 19 December 2022. - FY2022AdvancedAnnual report
「During the fiscal year, the Company developed, among other products, the Vivoly+ subscription service, a cloud-based endoscopy image and report management software offering for clinics with AI support.」
Regarding the use of ICT and AI, the Company developed a subscription service for cloud-based endoscopy image and report management software. - FY2021AdvancedAnnual report
「In October 2020, the Company also launched ENDO-AID, an AI-enabled endoscopy CAD platform, in Europe and parts of Asia.」
Regarding the direction of ICT and AI utilization, the Company advanced to the commercialization stage with the launch of the ENDO-AID endoscopy CAD platform. - FY2020AdvancedAnnual report
「In addition, the Company will consider initiatives for the new normal by identifying changes in ways of working and customer needs, reconsidering its operating and business models, and placing digitalization at the center of these efforts.」
In connection with the ICT-AI Platform Initiative, the Company indicated that it was considering the digitalization of its operating and business models in light of changes in ways of working and customer needs. - FY2019First statedAnnual report
「In addition, with regard to ICT and AI, areas the Company will focus on going forward, it has launched the ICT-AI Platform Initiative.」
The Company first explicitly announced the launch of a company-wide platform initiative for the ICT and AI areas it will focus on going forward.